We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Manufacturing Practices Slow Drug Development
FDA: Manufacturing Practices Slow Drug Development
March 17, 2006
The FDA believes that inadequate manufacturing processes are a main reason for slowdowns in the drug pipeline, a senior agency official says.